Shares of Jubilant Pharmova surged nearly 9% on September 9, hitting a record high of ₹1,038 after the company posted strong quarterly earnings and issued positive guidance.
Syngene stock price dropped after management issued cautious outlook during quarterly results. The company has reduced FY24 guidance due to slowdown in the US biotech segment.